Testosterone and Longevity: What Men Need to Know After 40

Testosterone occupies a strange place in men's health: simultaneously over-marketed by clinics selling vitality and under-discussed in routine primary care. The truth sits between those poles. Testosterone does decline with age — roughly 1% per year after 30, on average — but the decline is not uniform, not inevitable at the same rate for everyone, and not always the cause of the symptoms attributed to it.

The symptoms most reliably linked to genuinely low testosterone are reduced libido, erectile changes, loss of morning erections, fatigue, reduced muscle mass despite training, and low mood. The problem: every one of these has other common causes — poor sleep, depression, obesity, thyroid dysfunction, medication side effects.

This is why diagnosis requires more than a symptom checklist. Guidelines call for at least two morning blood draws (testosterone peaks early in the day), measured alongside related markers — LH, FSH, SHBG, estradiol, prolactin — to distinguish testicular from pituitary causes and to calculate free testosterone, which often matters more than the total number.

Observationally, low testosterone is associated with higher all-cause mortality, more cardiovascular disease, type 2 diabetes, and osteoporosis. But association is not causation — chronic illness lowers testosterone, so low levels are partly a marker of poor health rather than purely a cause of it.

The interventional evidence took a major step forward with the TRAVERSE trial (2023), which found testosterone therapy in middle-aged and older men with hypogonadism did not increase major adverse cardiac events versus placebo. That addressed the biggest historical safety concern, though the trial also observed higher rates of atrial fibrillation and pulmonary embolism — a reminder that "safe on the primary endpoint" is not "risk-free."

Before any conversation about therapy, the levers with the strongest evidence are unglamorous:

For men with confirmed hypogonadism and symptoms, testosterone therapy can meaningfully improve quality of life, body composition, and bone density. It also carries real considerations — fertility suppression, hematocrit monitoring, prostate screening — that require ongoing clinical oversight, not a one-time prescription.

Any decision about hormone therapy should be made with a licensed provider reviewing your full history and labs. That provider-led model is the only way VitalWay operates: data collection and monitoring on the platform, clinical judgment always with the clinician.